ArticleHeliyon2023

DMU-212 against EGFR-mutant non-small cell lung cancer via AMPK/PI3K/Erk signaling pathway.

Xiao-Ping Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.